BORA
Protein aurora borealis
Also known as: BORA_HUMAN, C13orf34, FLJ22624
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PGQ7
- Gene
- BORA
- Ensembl
- ENSG00000136122
- Chromosome
- 13
- Canonical length
- 559 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Cytosol
OverviewNCBI Gene
BORA is an activator of the protein kinase Aurora A (AURKA; MIM 603072), which is required for centrosome maturation, spindle assembly, and asymmetric protein localization during mitosis (Hutterer et al., 2006 [PubMed 16890155]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
559 residues, UniProt reviewed canonical sequence.
>Q6PGQ7|BORA
1 MGDVKESKMQ ITPETPGRIP VLNPFESPSD YSNLHEQTLA SPSVFKSTKL PTPGKFRWSI
61 DQLAVINPVE IDPEDIHRQA LYLSHSRIDK DVEDKRQKAI EEFFTKDVIV PSPWTDHEGK
121 QLSQCHSSKC TNINSDSPVG KKLTIHSEKS DAACQTLLSL PVDFNLENIL GDYFRADEFA
181 DQSPGNLSSS SLRRKLFLDG NGSISDSLPS ASPGSPHSGV QTSLEMFYSI DLSPVKCRSP
241 LQTPSSGQFS SSPIQASAKK YSLGSITSPS PISSPTFSPI EFQIGETPLS EQRKFTVHSP
301 DASSGTNSNG ITNPCIRSPY IDGCSPIKNW SPMRLQMYSG GTQYRTSVIQ IPFTLETQGE
361 DEEDKENIPS TDVSSPAMDA AGIHLRQFSN EASTHGTHLV VTAMSVTQNQ SSASEKELAL
421 LQDVEREKDN NTVDMVDPIE IADETTWIKE PVDNGSLPMT DFVSGIAFSI ENSHMCMSPL
481 AESSVIPCES SNIQMDSGYN TQNCGSNIMD TVGAESYCKE SDAQTCEVES KSQAFNMKQD
541 HTTQRCWMKT ASPFQCSSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BORA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 7.5 nTPM
Expression across tissuesHPA
Tissue
- thymus: 7.5 nTPM
- lymph node: 7.1 nTPM
- tonsil: 6.4 nTPM
- bone marrow: 5.7 nTPM
- rectum: 4.7 nTPM
- duodenum: 4.1 nTPM
Single-cell type
- epicardial cells: 36 nCPM
- late primary spermatocytes: 35 nCPM
- sertoli cells: 31 nCPM
- monocyte progenitors: 29 nCPM
- cardiomyocytes: 29 nCPM
- erythrocyte progenitors: 24 nCPM
Immune cell
- naive CD8 T-cell: 2.5 nTPM
- MAIT T-cell: 2.3 nTPM
- memory CD8 T-cell: 2 nTPM
- gdT-cell: 1.9 nTPM
- intermediate monocyte: 1.9 nTPM
- myeloid DC: 1.9 nTPM
Brain region
- choroid plexus: 2.6 nTPM
- medulla oblongata: 1.9 nTPM
- pons: 1.6 nTPM
- white matter: 1.6 nTPM
- cerebellum: 1.5 nTPM
- cerebral cortex: 1.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- -0.67
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- regulation of mitotic nuclear division
- regulation of mitotic spindle organization
- regulation of protein localization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aurora borealis protein
- Protein aurora borealis N-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BORA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BORA as an antibody target. Whether an autoantibody or antibody against BORA could matter depends on whether native BORA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BORA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BORA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...